Sfoglia per RIVISTA
UROLOGIC ONCOLOGY
Collezione AOU San Luigi di Orbassano
Items : 10
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data. in Urologic oncology / Urol Oncol. 2024 May;42(5):163.e1-163.e13. doi: 10.1016/j.urolonc.2024.01.028. Epub 2024 Mar 5.
2024
AOU San Luigi di Orbassano
Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; et alii...
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database. in Urologic oncology / Urol Oncol. 2024 Mar;42(3):69.e17-69.e25. doi: 10.1016/j.urolonc.2024.01.001. Epub 2024 Feb 1.
2024
AOU San Luigi di Orbassano
Porreca A; Di Nicola M; Lucarelli G; Dorin VM; Soria F; Terracciano D; Mistretta FA; Luzzago S; Buonerba C; Cantiello F; Mari A; Minervini A; Veccia A; Antonelli A; Musi G; Hurle R; Busetto GM; Del Giudice F; Ferretti S; Perdonà S; Prete PD; Porreca A; Bove P; Crisan N; Russo GI; Damiano R; Amparore D; Porpiglia F; Autorino R; et alii...
Topical instillation of BCG immunotherapy for biopsy-proven primary upper urinary tract carcinoma in situ: A single institution series and systematic review. in Urologic oncology / Urol Oncol. 2023 Jun;41(6):274-283. doi: 10.1016/j.urolonc.2022.11.001. Epub 2022 Dec 15.
2023
AOU San Luigi di Orbassano
Breda A; Palou J; Algaba F; Verri P; Izquierdo P; Gavrilov P; Gaya JM; Territo A; Huguet J; Baboudjian M; Gallioli A; Fontanet S;
Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysis. in Urologic oncology / Urol Oncol. 2023 Dec;41(12):487.e15-487.e23. doi: 10.1016/j.urolonc.2023.09.015. Epub 2023 Oct 23.
2023
AOU San Luigi di Orbassano
Saitta C; Afari JA; Autorino R; Capitanio U; Porpiglia F; Amparore D; Piramide F; Cerrato C; Meagher MF; Noyes SL; Pandolfo SD; Buffi NM; Larcher A; Hakimi K; Nguyen MV; Puri D; Diana P; Fasulo V; Saita A; Lughezzani G; Casale P; Antonelli A; Montorsi F; Lane BR; Derweesh IH;
Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study. in Urologic oncology / Urol Oncol. 2021 Jan;39(1):78.e17-78.e26. doi: 10.1016/j.urolonc.2020.09.022. Epub 2020 Oct 27.
2021
AOU San Luigi di Orbassano
Terrone C; Villari D; Tellini R; Schiavina R; Simeone C; Rocco B; Porreca A; Porpiglia F; Longo N; Montorsi F; Gallioli A; Di Maida F; Capitanio U; Brunocilla E; Barale M; Antonelli A; Allasia M; Nazzani S; Marra G; Gontero P; Mari A; Ficarra V; Carini M; Minervini A;
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study. in Urologic oncology / Urol Oncol. 2021 Apr;39(4):239.e1-239.e7. doi: 10.1016/j.urolonc.2021.01.003. Epub 2021 Feb 16.
2021
AOU San Luigi di Orbassano
ASL Città di Torino
Deuker M; Pecoraro A; Rosiello G; Stolzenbach F; Luzzago S; Tian Z; Shariat SF; Saad F; Briganti A; Kapoor A; Fiori C; Porpiglia F; Karakiewicz PI;
Bladder cancer incidence rates and trends in young adults aged 20-39 years. in Urologic oncology / Urol Oncol. 2020 Dec;38(12):934.e11-934.e19. doi: 10.1016/j.urolonc.2020.06.009. Epub 2020 Jul 9.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
Pecoraro A; Palumbo C; Rosiello G; Luzzago S; Deuker M; Stolzenbach F; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;
Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy. in Urologic oncology / Urol Oncol. 2015 Oct;33(10):424.e17-23. doi: 10.1016/j.urolonc.2015.05.032. Epub 2015 Jul 7.
2015
AOU San Luigi di Orbassano
De Luca S; Passera R; Fiori C; Bollito E; Cappia S; Mario Scarpa R; Sottile A; Franco Randone D; Porpiglia F;
Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger. in Urologic oncology / Urol Oncol. 2015 Jun;33(6):265.e15-21. doi: 10.1016/j.urolonc.2015.02.016. Epub 2015 Apr 20.
2015
AOU San Luigi di Orbassano
Caffo O; Ortega C; Di Lorenzo G; Sava T; De Giorgi U; Cavaliere C; Macrini S; Spizzo G; Aieta M; Messina C; Tucci M; Lodde M; Mansueto G; Zucali PA; Alesini D; D'Angelo A; Massari F; Morelli F; Procopio G; Ratta R; Fratino L; Lo Re G; Pegoraro MC; Zustovich F; Vicario G; Ruatta F; Federico P; La Russa F; Burgio SL; et alii...
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up. in Urologic oncology / Urol Oncol. 2005 Jan-Feb;23(1):1-7. doi: 10.1016/j.urolonc.2004.06.003.
2005
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Berruti A; Fara E; Tucci M; Tarabuzzi R; Mosca A; Terrone C; Gorzegno G; Fasolis G; Tampellini M; Porpiglia F; De Stefanis M; Fontana D; Bertetto O; Dogliotti L;